EVALUATION OF THE IMMUNE RESPONSE TO PNEUMOCOCCAL CAPSULAR POLYSACCHARIDES

REFERENCES

• Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. ClM Inf Dis. 1992;14:801–9.
   PubMed Web of Science ®Google Scholar
• Robinson KA, Baughman W, Rothrock G et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998. JAMA. 2001;285:1729–35.
   PubMed Web of Science ®Google Scholar
• Davidson R, Cavalcanti R, Brunton JL et al. Resistance to levofloxacin and failure of treatment of pneumococcal pneumoniae. N Engl J Med. 2002;346:747–50.
   PubMed Web of Science ®Google Scholar
• Peleman RA, Peetermans WE, Van Laethem Y et al. Prevention of pneumococcal disease: an update on the Belgian Consensus Report. Acta ClM Belg. 1999;54:321–7.
   PubMed Web of Science ®Google Scholar
• Ambrosino DM, Siber GR, Chilmonczyk BA, Jemberg JB, Finberg RW. An immunodeficiency characterized by impaired antibody response to polysaccharides. N Engl J Med. 1987;316:790–3.
   PubMed Web of Science ®Google Scholar
• Epstein MM, Gruskay F. Selective deficiency in pneumococcal antibody response in children with recurrent infections. Ann Al-lergy Asthma Immunol. 1995;75:125–31.
   Web of Science ®Google Scholar
• Gigliotti F, Herrod HG, Kalwinsky DK, Insel RA. Immunodefi-ciency associated with recurrent infections and an isolated in vivo inability to respond to bacterial polysaccharides. Pediatr Infect Dis J 1988; 7:417–20.
   PubMed Web of Science ®Google Scholar
• Hidalgo H, Moore C, Leiva L, Sorensen RU. Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections. Ann Allergy Asthma Immunol. 1996;76:341–6.
   Web of Science ®Google Scholar
• Wasserman RL Sorensen RU. Evaluating children with respira-tory tract infections: the role of immunization with bacterial polysaccharide vaccine. Pediatr Infect Dis J. 1999;18:157–63.
   Web of Science ®Google Scholar
• Bruyn GA, Zegers BJ, Van Furth R. Mechanisms of the host defense against infection with Streptococcus pneumoniae. Clin Inf Dis. 1992;14:251–62.
   PubMed Web of Science ®Google Scholar
• Briles DE, Claffin JL, Schroer K, Forman C. Mouse IgG3 anti-bodies are highly protective against infection with Streptococ-cus pneumoniae. Nature 1981;294:88–90.
   PubMed Web of Science ®Google Scholar
• MacLeod CM, Hodges R, Heidelberger M, Bernhard WG. Pre-vention of pneumococcal pneumonia by immunization with spe-cific capsular polysaccharides. J Exp Med 1945;82:445–65.
   Web of Science ®Google Scholar
• Neufeld F. Ueber die agglutination der pneumokokken und uber die theorieen der agglutination. Z Hyg Infectionskr 1902;40:54–72.
   Google Scholar
• Szu SC, Schneerson R, Robbins JB. Rabbit antibodies to cell wall polysaccharide to Streptococcus pneumoniae fail to protect mice from lethal challenge with encapsulated pneumococci. In-fect Immun. 1986;54:448–55.
   Web of Science ®Google Scholar
• Musher DM, Watson DA, Baughn E. Does naturally acquired IgG antibody to cell wall polysaccharide protect human sub-jects against pneumococcal infection? J Inf Dis 1990;161:736–40.
   PubMed Web of Science ®Google Scholar
• Tuomanen E, Liu H, Hengstler B, Zak O, Tomasz A. The induc-tion of meningeal inflammation by components of the pneumo-coccal cell wall. J Inf Dis. 1985;151:859–68.
   PubMed Web of Science ®Google Scholar
• Lee C, Banks SD, Li JP. Virulence, immunity, and vaccine re-lated to Streptococcus pneumoniae. Grit Rev Microbiol 1991;18:89–114.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, McDaniel LS, Kawabata K et al. Oral immuniza-tion with PspA elicits protective humoral immunity against Strep-tococcus pneumoniae infection. Infect Immun 1997;65:640–4.
   Web of Science ®Google Scholar
• Samukawa T, Yamanaka N, Hollingshead S, Murphy TF, Faden H. Immune response to surface protein A of Streptococcus pneumoniae and the high-molecular-weight outer membrane protein A of Moraxella catarrhalis in children with acute otitis media. J Inf Dis. 2000;181:1842–5.
   Web of Science ®Google Scholar
• Howard JG, Christie GH, Courtney BM, Leuchars E, Davies AJ. Studies on immunological paralysis. VI. Thymic-independ-ence of tolerance and immunity to type 3 pneumococcal polysac-charide. Cell. Immunol. 1971;2:614–626.
   PubMed Web of Science ®Google Scholar
• Humphrey JH, Parrot DM, East J. Studies on globulin and anti-body production in mice at birth. Immunology 1964;7:419–25.
   PubMed Web of Science ®Google Scholar
• Rijkers GT, Dollekamp I, Zegers BJ. 8-Mercaptoguanosine over-comes unresponsiveness of human neonatal cells to polysaccha-ride antigens. J. Immunol. 1988;14:2313–6.
   Google Scholar
• Rijkers GT, Dollekamp EG and Zegers BJ. The in vitro B-cell response to pneumococcal polysaccharides in adults and neonates. Scand. J. Immunol. 1987;25: 447–52.
   Web of Science ®Google Scholar
• Noelle RJ, Roy M, Shephard DM, Stamenkovics I, Ledbetter JA, Aruffo AA. A 39-kDa protein on activated helper T-cells binds CD40 and transduces the signal for cognate activation of B cell. Proc. Natl. Acad. Sci. USA 1992;89:6550–4.
   PubMed Web of Science ®Google Scholar
• Jeurissen A, Wuyts M, Kasran A, et al. Essential role for CD40 ligand interactions in T lymphocyte-mediated modulation of the murine immune response to pneumococcal capsular polysaccharides. J Immunol. 2002;168:2773–81.
   Web of Science ®Google Scholar
• Zora JA, Silk HJ, Tinkelman DG. Evaluation of postimmunization pneumococcal titers in children with recur-rent infections and normal levels of immunoglobulin. Ann Al-lergy Asthma Immunol 70;283–7.
   Web of Science ®Google Scholar
• Ekdahl K, BraconierJH, Svanborg C. Immunoglobulin deficien-cies and impaired immune respons to polysaccharide antigens in adult patients with recurrent community acquired pneumo-nia. Scand J Infect Dis 1997;29:401–7.
   PubMed Web of Science ®Google Scholar
• Ekdahl K, Braconier JH, Svanborg C. Impaired antibody response to pneumococcal capsular polysaccharides and phosphorylcholine in adult patients with a history of bacteremic pneumococcal infection. Clin Inf Dis 1997;25:654–60.
   Web of Science ®Google Scholar
• Javier FC, Cleveland MM, Sorensen RU. Distribution of pri-mary immunodeficiency diseases diagnosed in a pediatric terti-ary hospital. Ann Allergy Asthma Immunol 2000;84:25–30.
   Web of Science ®Google Scholar
• Sorensen RU, Moore C. Antibody deficiency syndromes. Pediatr Clin N Am ; 47: 1225–52.
   Web of Science ®Google Scholar
• Sorensen RU, Hidalgo H, Moore C, Leiva LE. Post-immuniza-tion pneumococcal antibody titers and IgG subclasses. Pediatr Pulmonol. 1996;22:167–73.
   PubMed Web of Science ®Google Scholar
• Hedlund J, Ortqvist A, Konradsen HB, Kalin M. Recurrence of pneumoniae in relation to the antibody response after pneumo-coccal vaccination in middle-aged and elderly adults. Scand J Infect Dis 2000;32:281.
   PubMed Web of Science ®Google Scholar
• Turner MW. Mannose binding lectin in health and disease. Immunobiology 1998;199:327–39.
   PubMed Web of Science ®Google Scholar
• Jeurissen A, Bossuyt X, Opdenakker G. Het belang van mannosebindend lectine in de activatie van de complementcascade. Tijdschr Gen 2002;58:991–998.
   Google Scholar
• Bax WA, Cluysenaer OJ, Bartelink AK, Aerts PC, Ezekowitz RA, Van Dijk H. Immunologie in de medische praktijk. XXVIII. Gevoeligheid voor meningokokkenziekte door een familiair tekort aan mannosebindend lectine. Ned Tijdschr Geneesku 2000;144:1219–1223.
   Google Scholar
• Sanders LA, Rijkers GT, Kuis W et al. Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections. J Allergy Clin Immunol 1993;91:110–9.
   PubMed Web of Science ®Google Scholar
• Rijkers GT, Sanders EAM, Breukels MA, Voorhorst-Ogink MM, Zegers BMJ. Humorale immuunrespons tijdens pneumokokken infecties voor en na vaccinatie met polysaccharide en conjugaat pneumokokken vaccins. Boehaave Commis sie 23.01.1998. Pneumokokken infecties en pneumokokken vaccinaties.
   Google Scholar
• Verhaegen J, Van de Ven J, Verbiest N, Van Eldere J, Verbist L. Evolution of Streptococcus pneumoniae serotypes and antibi-otic resistance in Belgium — update (1994-98). Clin Microbiol Infect 2000;6:308–15.
   PubMed Web of Science ®Google Scholar